Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Equillium Q4 2023 GAAP EPS $(0.07) Beats $(0.17) Estimate, Sales $9.200M Beat $6.425M Estimate

Author: Benzinga Newsdesk | March 25, 2024 04:02pm
Equillium (NASDAQ:EQ) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.17) by 58.82 percent. The company reported quarterly sales of $9.200 million which beat the analyst consensus estimate of $6.425 million by 43.19 percent. This is a 41.62 percent decrease over sales of $15.759 million the same period last year.

Posted In: EQ


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist